Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.9M Buy
33,751
+288
+0.9% +$103K 0.05% 194
2025
Q4
$11M Sell
33,463
-12,614
-27% -$4M 0.04% 196
2025
Q3
$13M Buy
46,077
+2,977
+7% +$863K 0.06% 176
2025
Q2
$12M Sell
43,100
-622
-1% -$176K 0.06% 177
2025
Q1
$13.6M Sell
43,722
-294
-0.7% -$86.8K 0.07% 154
2024
Q4
$11.5M Sell
44,016
-7,208
-14% -$2.14M 0.06% 163
2024
Q3
$16.5M Sell
51,224
-476
-0.9% -$156K 0.09% 134
2024
Q2
$16.2M Sell
51,700
-6,177
-11% -$1.81M 0.09% 126
2024
Q1
$16.5M Buy
57,877
+15,211
+36% +$4.45M 0.1% 126
2023
Q4
$12.3M Buy
42,666
+3,480
+9% +$948K 0.08% 144
2023
Q3
$10.5M Buy
39,186
+108
+0.3% +$27K 0.08% 149
2023
Q2
$8.68M Sell
39,078
-1,502
-4% -$349K 0.06% 167
2023
Q1
$9.81M Sell
40,580
-479
-1% -$118K 0.07% 158
2022
Q4
$10.8M Sell
41,059
-4,847
-11% -$1.3M 0.08% 143
2022
Q3
$10.3M Sell
45,906
-1,434
-3% -$348K 0.08% 144
2022
Q2
$11.5M Buy
47,340
+810
+2% +$198K 0.09% 142
2022
Q1
$11.3M Buy
46,530
+2,477
+6% +$569K 0.07% 158
2021
Q4
$9.91M Buy
44,053
+4,962
+13% +$1.05M 0.07% 171
2021
Q3
$8.31M Buy
39,091
+1,989
+5% +$458K 0.06% 185
2021
Q2
$9.04M Buy
37,102
+1,431
+4% +$352K 0.07% 172
2021
Q1
$8.88M Buy
35,671
+10,584
+42% +$2.53M 0.07% 159
2020
Q4
$5.77M Buy
25,087
+874
+4% +$202K 0.05% 190
2020
Q3
$6.15M Buy
+24,213
New +$6M 0.07% 166
2020
Q2
Sell
-26,802
Closed -$5.43M 637
2020
Q1
$5.43M Sell
26,802
-2,987
-10% -$652K 0.08% 146
2019
Q4
$7.18M Sell
29,789
-6,232
-17% -$1.37M 0.08% 141
2019
Q3
$6.97M Buy
36,021
+6,614
+22% +$1.27M 0.08% 138
2019
Q2
$5.42M Buy
29,407
+18,206
+163% +$3.26M 0.07% 157
2019
Q1
$2.13M Buy
11,201
+3,308
+42% +$632K 0.03% 264
2018
Q4
$1.54M Sell
7,893
-18
-0.2% -$3.51K 0.02% 304
2018
Q3
$1.64M Sell
7,911
-226
-3% -$44.5K 0.02% 319
2018
Q2
$1.38M Buy
8,137
+156
+2% +$27.6K 0.02% 332
2018
Q1
$1.36M Sell
7,981
-13,180
-62% -$2.42M 0.02% 345
2017
Q4
$3.68M Buy
21,161
+1,518
+8% +$269K 0.05% 205
2017
Q3
$3.66M Buy
19,643
+329
+2% +$58.3K 0.05% 200
2017
Q2
$3.33M Buy
19,314
+682
+4% +$111K 0.06% 190
2017
Q1
$3.06M Sell
18,632
-21,152
-53% -$3.51M 0.05% 216
2016
Q4
$5.82M Buy
39,784
+32,162
+422% +$4.84M 0.09% 150
2016
Q3
$1.27M Buy
7,622
+689
+10% +$117K 0.02% 378
2016
Q2
$1.06M Buy
6,933
+190
+3% +$29.5K 0.02% 373
2016
Q1
$1.01M Sell
6,743
-7,333
-52% -$1.09M 0.02% 355
2015
Q4
$2.29M Buy
14,076
+209
+2% +$32.9K 0.05% 235
2015
Q3
$1.92M Sell
13,867
-15,812
-53% -$2.49M 0.04% 264
2015
Q2
$4.52M Buy
29,679
+3,619
+14% +$580K 0.09% 163
2015
Q1
$4.17M Sell
26,060
-1,269
-5% -$200K 0.11% 134
2014
Q4
$4.35M Sell
27,329
-13,438
-33% -$2.09M 0.11% 127
2014
Q3
$5.73M Buy
40,767
+19,555
+92% +$2.55M 0.12% 107
2014
Q2
$2.51M Sell
21,212
-14,180
-40% -$1.64M 0.05% 183
2014
Q1
$4.37M Buy
35,392
+5,537
+19% +$672K 0.1% 127
2013
Q4
$3.41M Buy
29,855
+9,575
+47% +$1.09M 0.08% 145
2013
Q3
$2.27M Buy
+20,280
New +$2.2M 0.06% 167

Other funds holding AMGN

Scotia Capital's AMGN Position: Q1 2026 in Review

Scotia Capital increased its Amgen (AMGN) stake by 0.86% in Q1 2026, buying an estimated $103K and bringing the position to 33,751 shares worth $11.9M. The position accounts for 0.05% of the portfolio, ranked #194.

Scotia Capital first reported a position in AMGN in Q3 2013 and has held it in 50 quarters since. The position peaked at $16.5M in Q3 2024. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Scotia Capital held 33,751 shares of Amgen worth $11.9M as of Q1 2026.
  • Scotia Capital bought 288 Amgen shares in Q1 2026, an estimated $103K.
  • Amgen made up 0.05% of Scotia Capital's portfolio in Q1 2026, its #194 holding.
  • Scotia Capital first reported a position in Amgen in Q3 2013 and has held it in 50 quarters since.
  • Scotia Capital's Amgen position peaked at $16.5M in Q3 2024.
  • 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Scotia Capital's 13F filing for Q1 2026, filed 13 May 2026.